✦ LIBER ✦

P-067 Impact of mismatch repair protein expression on cisplatinum-basedchemotherapeutic response in patients with stage III non-small-cell lung cancer (NSCLC)

✍ Scribed by Korfee, S.; Pötttgen, C.; Cortés-Incio, D.; Müller, M.; Kaczmarczyk, P.; Theegarten, D.; Gauler, L.; Krbek, T.; Seeber, S.; Eberhardt, W.

Book ID: 118572975
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 153 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80561-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-151 Correlations between clinical resp

P-151 Correlations between clinical response to cisplatin or oxaliplatin and expression of the Mismatch Repair (MMR) and p53 in advanced non-small cell lung cancer (NSCLC) patients

✍ Franciosi, Vittorio; Campanini, Nicoletta; Bozzetti, Cecilia; Perrone, Antoniett 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Prognostic Impact of VEGF and VEGF Recep

Prognostic Impact of VEGF and VEGF Receptor 1 (FLT1) Expression in Patients Irradiated for Stage II/III Non-Small Cell Lung Cancer (NSCLC)

✍ Dirk Rades; Cornelia Setter; Juergen Dunst; Olav Dahl; Steven E. Schild; Frank N 📂 Article 📅 2010 🏛 Springer 🌐 German ⚖ 1020 KB

P-075 A comprehensive evaluation of tumo

P-075 A comprehensive evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers (NSCLC)

✍ Le, Q.; Chen, E.; Salim, A.; Cao, H.; Kong, C.; O'Byrne, K.; Mitchell, J.; Donin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 147 KB

P-629 Decrease in the expression of stru

P-629 Decrease in the expression of structural proteins with nochanges in satellite cells in skeletal muscles of patients with early-stage non-small cell lung cancer (ES-NSCLC)

✍ Martinez-Llorens, J.; Curull, V.; Casadevall, C.; Minguella, J.; Barreiro, E.; O 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

P-472 Impact of EGF-R, Her-2-neu and c-k

P-472 Impact of EGF-R, Her-2-neu and c-kit-overexpression on overall survival in patients (pts) with stage III (N2/N3) non-small-cell lung cancer (NSCLC)

✍ Korfee, Sönke; Müller, Mark-Roland; Cortes-Incio, Diana; Pöttgen, Christoph; Kac 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

143P CISPLATINUM PLUS DOCETAXEL (CD) AS

143P CISPLATINUM PLUS DOCETAXEL (CD) AS INDUCTION CHEMOTHERAPY PRIOR TO RADICAL LOCOREGIONAL (LR) TREATMENT FOR PATIENTS (PTS) WITH STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A PROSPECTIVE PHASE II STUDY

✍ Berros, J.P.; Esteban, E.; Crespo, G.; Muriel, C.; Sanmamed, M.F.; Pardo, P.; Iz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB